Genmab GMAB

COP: GMAB | ISIN: DK0010272202   8/05/2024
2.003,00 DKK (-0,45%)
(-0,45%)   8/05/2024

7 mei 2024 · Capital Increase in Genmab as a Result of Employee Warrant Exercise · Persbericht

6 mei 2024 · Transactions in Connection with Share Buy-back Program · Persbericht

2 mei 2024 · Genmab Announces Financial Results for the First Quarter of 2024 · Persbericht

30 april 2024 · TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer · Persbericht

29 april 2024 · Transactions in Connection with Share Buy-back Program Genmab · Persbericht

22 april 2024 · Transactions in Connection with Share Buy-back Program Genmab · Persbericht

16 april 2024 · Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024 · Persbericht

15 april 2024 · Transactions in Connection with Share Buy-back Program Genmab · Persbericht

8 april 2024 · Transactions in Connection with Share Buy-back Program · Persbericht

3 april 2024 · Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio · Persbericht

2 april 2024 · Transactions in Connection with Share Buy-back Program · Persbericht

25 maart 2024 · Transactions in Connection with Share Buy-back Program · Persbericht

18 maart 2024 · Completion of share buy-back program · Persbericht

15 maart 2024 · Genmab Announces Initiation of Share Buy-Back Program · Persbericht

13 maart 2024 · Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons · Persbericht

13 maart 2024 · Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab · Persbericht

13 maart 2024 · Passing of Genmab A/S’ Annual General Meeting · Persbericht

11 maart 2024 · Transactions in connection with share buy-back program · Persbericht

4 maart 2024 · Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons · Persbericht

4 maart 2024 · Transactions in connection with share buy-back program · Persbericht

Mijn selecties